Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
Apply
IMC-F106C vs. Nivolumab
IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step